Ben Jenkins

MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion

Prerna Mehta, Ben Jenkins, Lauren McCarthy et al. · Oncogene · 2003 · 182 citations

Metastatic Prostate Cancer, Urology, Oncology +10

Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer

Nicholas C. Turner, Claire Swift, Ben Jenkins et al. · Annals of Oncology · 2022 · 173 citations · Full text

Phase 1, dose-escalation study of guadecitabine (SGI-110) in combination with pembrolizumab in patients with solid tumors

Dionysis Papadatos-Pastos, Wei Yuan, Abhijit Pal et al. · Journal for ImmunoTherapy of Cancer · 2022 · 47 citations · Full text

Updated outcomes of POUT: A phase III randomized trial of peri-operative chemotherapy versus surveillance in upper tract urothelial cancer (UTUC).

Alison Birtle, John Chester, Robert J. Jones et al. · Journal of Clinical Oncology · 2021 · 21 citations

Surgical Oncology, Cancer Management, Adjuvant Chemotherapy +16

Abstract GS3-06: Primary results of the cTRAK TN trial: A clinical trial utilising ctDNA mutation tracking to detect minimal residual disease and trigger intervention in patients with moderate and high risk early stage triple negative breast cancer

Nicholas C. Turner, Claire Swift, Ben Jenkins et al. · Cancer Research · 2022 · 14 citations

Breast Oncology, Adjuvant Chemotherapy, Pathology +20